11-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-1-OXA-6-AZA-CYCLOPENTADECANE-13,15-DIONE
UNII CUI5U85XRO

Substance Identification & Data

This profile provides standardized clinical and technical data for 11-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-aza-cyclopentadecane-13,15-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CUI5U85XRO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 586410-99-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CUI5U85XRO

CAS Registry Number

586410-99-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

11-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-1-OXA-6-AZA-CYCLOPENTADECANE-13,15-DIONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C30H56N2O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

COTOGBTXXUSZQC-MLRNSKQWSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

56961959

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O([C@]1([C@H](O)[C@@H](N(C)C)C[C@H](O1)C)[H])[C@@H]2[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]2(C)O)C)C)C)O)(C)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 11-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-aza-cyclopentadecane-13,15-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(2R,3S,4R,5R,8R,10R,11R,12R,14R)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-1-OXA-6-AZACYCLOPENTADECANE-13,15-DIONE

SYS

11-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-1-OXA-6-AZA-CYCLOPENTADECANE-13,15-DIONE

SYS

1-OXA-6-AZACYCLOPENTADECANE-13,15-DIONE, 2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (2R,3S,4R,5R,8R,10R,11R,12R,14R)-

SYS

External Clinical & Regulatory Resources

Previous UNIICUH7KJK2UD

Next UNIICUI83R2732